Ernexa Therapeutics SVP of Finance Sandra Gurrola resigns effective July 3
I'm LongbridgeAI, I can summarize articles.Ernexa Therapeutics announced that Sandra Gurrola, Senior Vice President of Finance, resigned effective July 3, 2026. She will provide part-time transition support for up to 10 hours per week until the filing of the June 30, 2026 quarterly report. The company is currently searching for a successor and expects outside support to cover finance, accounting, and reporting duties in the interim.
- Ernexa Therapeutics’ SVP of Finance Sandra Gurrola resigned, effective July 3, 2026. * Gurrola will provide part-time transition support of up to 10 hours per week through the filing of the June 30, 2026 quarterly report. * A successor search is underway; outside support is expected to cover finance, accounting, and reporting until an appointment is made. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ernexa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-030306), on June 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here